{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:50:41Z","timestamp":1760100641402},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T00:00:00Z","timestamp":1384473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0079810","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T22:57:32Z","timestamp":1384556252000},"page":"e79810","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Inhibition of Survivin Influences the Biological Activities of Canine Histiocytic Sarcoma Cell Lines"],"prefix":"10.1371","volume":"8","author":[{"given":"Hiroki","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Hosoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,11,15]]},"reference":[{"key":"ref1","first-page":"1041","article-title":"Canine histyocytic neoplasia: an overview","volume":"48","author":"AR Fulmer","year":"2007","journal-title":"Can Vet J"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2460\/javma.239.1.90","article-title":"Evaluation and comparison of outcomes in dogs with periarticular and nonperiarticular histiocytic sarcoma","volume":"239","author":"SL Klahn","year":"2011","journal-title":"J Am Vet Med Assoc"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1939-1676.2007.tb02937.x","article-title":"CCNU for the treatment of dogs with histiocytic sarcoma","volume":"21","author":"KA Skorupski","year":"2007","journal-title":"J Vet Intern Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1939-1676.2010.0588.x","article-title":"Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma","volume":"24","author":"KM Rassnick","year":"2010","journal-title":"J Vet Intern Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1354\/vp.43-5-632","article-title":"Canine hemophagocytic histiocytic sarcoma: a proliferative disorder of CD11d+ macrophages","volume":"43","author":"PF Moore","year":"2007","journal-title":"Vet Pathol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jcpa.2011.05.006","article-title":"Paraneoplastic syndrome in haemophagocytic histiocytic sarcoma in a dog","volume":"146","author":"T Soare","year":"2012","journal-title":"J Comp Pathol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/25141","article-title":"Control of apoptosis and mitotic spindle checkpoint by survivin","volume":"396","author":"F Li","year":"1998","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.1038\/onc.2008.302","article-title":"IAP-targeted therapies for cancer","volume":"27","author":"EC LaCasse","year":"2008","journal-title":"Oncogene"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm0897-917","article-title":"A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma","volume":"3","author":"G Ambrosini","year":"1997","journal-title":"Nat Med"},{"key":"ref10","first-page":"1235","article-title":"Down-regulation of survivin expression reversed multidrug resistance in adriamycin-resistant HL-60\/ADR cell line","volume":"24","author":"J Walig\u00f3rska-Stachura","year":"2003","journal-title":"Acta Pharmacol Sin"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.yexcr.2004.12.014","article-title":"Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription","volume":"305","author":"T Endoh","year":"2005","journal-title":"Exp Cell Res"},{"key":"ref12","first-page":"537","article-title":"Survivin-prognostic tumor biomarker in human neoplasms-review","volume":"83","author":"J Walig\u00f3rska-Stachura","year":"2012","journal-title":"Ginekol Pol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1158\/0008-5472.CAN-11-2315","article-title":"Expression and function of survivin in canine osteosarcoma","volume":"72","author":"JK Shoeneman","year":"2012","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4161\/cc.1.5.149","article-title":"Elevation of survivin levels by hematopoietic growth factors occurs in quiescent CD34+ hematopoietic stem and progenitor cells before cell cycle entry","volume":"1","author":"S Fukuda","year":"2002","journal-title":"Cell Cycle"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"15100","DOI":"10.1073\/pnas.0406665101","article-title":"Cell division and cell survival in the absence of survivin","volume":"101","author":"D Yang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1084\/jem.20032092","article-title":"Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death","volume":"199","author":"H Okada","year":"2004","journal-title":"J Exp Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.immuni.2005.03.012","article-title":"Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion","volume":"22","author":"J Song","year":"2005","journal-title":"Immunity"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/10425170500213696","article-title":"Expression of survivin mRNA in dog tumors","volume":"16","author":"T Uchide","year":"2005","journal-title":"DNA Seq"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/jso.20507","article-title":"Expression of survivin and correlation with PCNA in osteosarcoma","volume":"93","author":"W Wang","year":"2006","journal-title":"J Surg Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1158\/0008-5472.CAN-04-4284","article-title":"A survivin gene signature predicts aggressive tumor behavior","volume":"65","author":"W Salz","year":"2005","journal-title":"Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1292\/jvms.10-0119","article-title":"Small interfering RNA (siRNA) against the survivin gene increases apoptosis in a canine melanoma cell line","volume":"72","author":"M Moriyama","year":"2010","journal-title":"J Vet Med Sci"},{"key":"ref22","first-page":"253","article-title":"Small interfering RNA-based molecular therapy of cancers","volume":"24","author":"W Guo","year":"2013","journal-title":"Chin J Cancer"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4155\/tde.12.136","article-title":"siRNA therapeutics in the treatment of diseases","volume":"4","author":"S Bakhtiyari","year":"2013","journal-title":"Ther Deliv"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1292\/jvms.68.1343","article-title":"Establishment and biological characterization of canine histiocytic sarcoma cell lines","volume":"68","author":"D Azakami","year":"2006","journal-title":"J Vet Med Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1292\/jvms.65.731","article-title":"Establishment of a new canine cell line (CCT) originated from a cutaneous malignant histiocytosis","volume":"65","author":"H Sakai","year":"2003","journal-title":"J Vet Med Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1292\/jvms.11-0435","article-title":"Pro-apoptotic effects of tepoxalin, a cyclooxygenase \/lipoxygenase dual inhibitor, on canine synovial fibroblasts","volume":"74","author":"T Sunaga","year":"2012","journal-title":"J Vet Med Sci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.vetimm.2007.01.011","article-title":"Development and application of multiple internal reference (housekeeper) gene assays for accurate normalisation of canine gene expression studies","volume":"117","author":"IR Peters","year":"2007","journal-title":"Vet Immunol Immunopathol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1292\/jvms.09-0575","article-title":"Quantitative analysis of mRNA for 10 different drug resistance factors in dogs with lymphoma","volume":"72","author":"H Tomiyasu","year":"2010","journal-title":"J Vet Med Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.vetimm.2008.12.004","article-title":"A GeNorm algorithm-based selection of reference genes for quantitative real-time PCR in skin biopsies of healthy dogs and dogs with atopic dermatitis","volume":"129","author":"YM Schlotter","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.rvsc.2004.07.008","article-title":"High expression of Bcl-xL in delayed apoptosis of canine neutrophils induced by lipopolysaccharide","volume":"78","author":"J Sano","year":"2005","journal-title":"Res Vet Sci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1476-4598-5-34","article-title":"Specific down-regulation of XIAP with RNA interference enhances the sensitivity of canine tumor cell-lines to TRAIL and doxorubicin","volume":"5","author":"B Spee","year":"2006","journal-title":"Mol Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"SF Altschul","year":"1990","journal-title":"J Mol Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/MPA.0b013e3181c31314","article-title":"Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells","volume":"39","author":"YB Hong","year":"2010","journal-title":"Pancreas"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1158\/1078-0432.CCR-10-3410","article-title":"Antitumor activity of YM155, a selective small-molecule survivin suppressant, alone and in combination with docetaxel in human malignant melanoma models","volume":"17","author":"K Yamanaka","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.4049\/jimmunol.172.6.3922","article-title":"Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells","volume":"172","author":"K Asanuma","year":"2004","journal-title":"J Immunol"},{"key":"ref36","first-page":"1469","article-title":"Survivin transcription is associated with P-glycoprotein\/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells","volume":"23","author":"F Liu","year":"2010","journal-title":"Oncol Rep"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1248\/bpb.30.2279","article-title":"The effect of survivin on multidrug resistance mediated by P-glycoprotein in MCF-7 and its adriamycin resistant cells","volume":"30","author":"F Liu","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"ref38","first-page":"2542","article-title":"Protein expression and significance of survivin and NF-\u03baB in hepatocellular carcinoma","volume":"91","author":"Y Jin","year":"2011","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e55710","DOI":"10.1371\/journal.pone.0055710","article-title":"The detergent-soluble cytoplasmic pool of survivin suppresses anoikis and its expression is associated with metastatic disease of human colon cancer","volume":"8","author":"M Hori","year":"2013","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1158\/1535-7163.MCT-07-0336","article-title":"Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells","volume":"6","author":"KM Rahman","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"ref41","first-page":"2013","article-title":"Vascular endothelial growth factor induces multidrug resistance-associated protein 1 overexpression through phosphatidylinositol-3-kinase \/protein kinase B signaling pathway and transcription factor specificity protein 1 in BGC823 cell line","volume":"13","author":"J Li","year":"2013","journal-title":"Acta Biochim Biophys Sin"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3892\/ijo.2013.1805","article-title":"Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by activating the ATM\/NF-\u03baB pathway in lung cancer cells","volume":"42","author":"SZ Ke","year":"2013","journal-title":"Int J Oncol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.cbi.2013.03.009","article-title":"Avermectin induces P-glycoprotein expression in S2 cells via the calcium\/calmodulin\/NF-\u03baB pathway","volume":"203","author":"L Luo","year":"2013","journal-title":"Chem Biol Interact"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1746-6148-8-78","article-title":"Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, \u03b2-catenin, p53, caspase 3) in canine appendicular osteosarcoma","volume":"8","author":"L Bongiovanni","year":"2012","journal-title":"BMC Vet Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.cr.7290046","article-title":"The IAP family: endogenous caspase inhibitors with multiple biological activities","volume":"10","author":"YL Yang","year":"2000","journal-title":"Cell Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/jso.22134","article-title":"Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer","volume":"105","author":"XY Chu","year":"2012","journal-title":"J Surg Oncol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1158\/0008-5472.CAN-10-0194","article-title":"Survivin enhances motility of melanoma cells by supporting Akt activation and {alpha}5 integrin upregulation","volume":"70","author":"JA McKenzie","year":"2010","journal-title":"Cancer Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/annonc\/mdr353","article-title":"A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer","volume":"23","author":"AW Tolcher","year":"2012","journal-title":"Ann Oncol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1200\/JCO.2008.21.1862","article-title":"Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer","volume":"27","author":"G Giaccone","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/15257771003597733","article-title":"Down-modulation of survivin expression and inhibition of tumor growth in vivo by EZN-3042, a locked nucleic acid antisense oligonucleotide","volume":"29","author":"P Sapra","year":"2010","journal-title":"Nucleosides Nucleotides Nucleic Acids"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0079810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:33:26Z","timestamp":1588966406000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0079810"}},"subtitle":[],"editor":[{"given":"Rolf","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,15]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0079810","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,15]]}}}